Publicly Funded Vaccines
This information about publicly funded vaccines is for pharmacists who are authorized to administer them.
[Page last updated on April 9, 2021]
PharmaCare pays a fee for publicly funded vaccines only when a pharmacist administers the vaccine by injection to B.C. residents who meet the eligibility criteria. See the B.C. Immunization Manual for the criteria, immunization schedule and other important information.
Vaccines must be administered by an authorized pharmacist. Vaccinations provided by other healthcare professionals, such as nurses hired for pharmacy clinics, cannot be claimed.
For administering publicly funded vaccines to eligible patients:
- Use the appropriate PIN (whether or not the product is eligible for an injection fee)
- Enter the quantity as the fluid volume of the vaccine (e.g., 0.5 mL)
- Do not enter a drug cost or fee
- The only intervention code that is acceptable for publicly funded flu shots is DE (ADJUDICATE TO $0.00 AS REQUESTED)
For administering a vaccine to patients who are not eligible for publicly funded vaccines:
- Dispense the vaccine ordered from your private supplier
- Use the product’s DIN
- Charge the patient directly
Important: Record the lot number for every vaccine administered to each patient in your pharmacy records. Recording vaccine lot numbers is required in case of rare events such as a vaccine recall or an adverse event following immunization (AEFI).
COVID-19 vaccine PINs
The BCPhA, with the Ministry of Health, has created a guide with details about PharmaNet data entry (unique to the COVID-19 vaccine), inventory tracking using your office use medication PHN (O-Med), cold-chain reporting, reimbursement, after-care and how to manage and report adverse events following immunization (AEFI), how to prevent and report wastage, and other details essential to pharmacies administering the vaccine.
- See the COVID-19 Immunization Guide for B.C. Community Pharmacies
- See the PharmaNet Cheat Sheet: COVID-19 Vaccines
- See the list of engaged pharmacies
- Read more about the roll-out to community pharmacies in the PharmaCare Newsletter
For guidelines for an informed-consent conversation with a client and a health assessment before administering a vaccine, please see the BCCDC's COVID19 vaccine screening checklist (PDF).
Additional information is in the BC Immunization Manual, Part 4 – Biological Products, COVID-19 vaccines.
|Vaccine Product Group||Brand||Vaccine Product||PIN|
|COVID-19||AstraZeneca||COVID-19 Vaccine (ChAdOx1-S [recombinant])||
Applies to both 8-dose and 10-dose vials
Manufacturer: Verity Pharmaceuticals and Serum Institute of India (SII) in collaboration with AstraZeneca
|COVID-19 Vaccine (ChAdOx1-S [recombinant])||66127322|
Pharmacists may offer a publicly funded influenza vaccine to eligible B.C. residents as soon as it becomes available in their community. For information on when supplies will be made available, consult your local health unit or health authority. PINs for seasonal influenza vaccination claims submissions are effective September 1, 2020 until June 1, 2021.
Note: Seasonal flu vaccine PINs are only active between September 1 and June 1 of each year.
Inclusion of a product in the lists below does not guarantee that the product is available. Recent additions to the list are indicated with an asterisk (*).
|Vaccine Product Group||Vaccine Product||PIN|
|FluMist® (Admin Fee)*||66128276|
|Vaccine Product Group||Vaccine Product||PIN|
|Haemophilus b conjugate||Act-HIB®||66128205|
|Haemophilus influenzae type b conjugate||Hiberix®||66128170|
|Havrix® Junior 720||66124769|
|Hepatitis B||Engerix® B||66124764|
|Engerix® B Pediatric||66128130|
|Recombivax HB® Adult Dialysis||66124790|
|Recombivax HB® Pediatric||66124791|
|Human papillomavirus (2 strains)||Cervarix™||66127902|
|Human papillomavirus (9 strains)||Gardasil® 9||66128117|
|Measles, mumps, rubella||MMR-II™||66124781|
|Measles, mumps, rubella, and varicella virus||Proquad®||66128068|
|Meningococcal group B||Bexsero||66128075|
|Meningococcal C conjugate||Meningitec™||66124832|
|Pneumococcal conjugate 13-valent||Prevnar 13||66128070|
|Pneumococcal 23-valent||Pneumovax® 23||66124785|
|IPV (polio for travel indications)||Imovax® Polio||66124773|
|Quadrivalent meningococcal conjugate||Menveo||66128071|
|Tetanus, diphtheria||Td Adsorbed||66124793|
|Tetanus, diphtheria, acellular pertussis||Adacel®||66124758|
|Tetanus, diphtheria, acellular pertussis, polio adsorbed||Quadracel®||66124787|
|Tetanus, diphtheria, acellular pertussis, polio, hepatitis B, haemophilus influenzae type b adsorbed||Infanrix hexa®||66124776|
|Tetanus, diphtheria, IPV (polio for travel indications)||Td Polio Adsorbed||66124792|